Orchard Therapeutics plc
ORTX · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$151 | -$145 | -$152 | -$163 |
| Dep. & Amort. | $3 | $2 | $2 | $2 |
| Deferred Tax | -$3 | $1 | -$2 | -$6 |
| Stock-Based Comp. | $16 | $23 | $28 | $19 |
| Change in WC | $36 | -$17 | -$4 | -$18 |
| Other Non-Cash | $23 | $11 | $2 | $0 |
| Operating Cash Flow | -$76 | -$125 | -$126 | -$166 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$7 | -$3 | -$13 | -$4 |
| Net Acquisitions | $0 | $1 | $0 | $305 |
| Inv. Purchases | -$112 | -$264 | -$113 | -$414 |
| Inv. Sales/Matur. | $201 | $235 | $281 | $109 |
| Other Inv. Act. | $8 | -$1 | $2 | -$305 |
| Investing Cash Flow | $91 | -$32 | $157 | -$309 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $154 | $0 | $130 |
| Stock Repurch. | -$0 | -$0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$1 | $158 | $4 | $157 |
| Financing Cash Flow | -$1 | $158 | $4 | $157 |
| Forex Effect | -$1 | -$0 | $1 | $2 |
| Net Chg. in Cash | $12 | $1 | $36 | -$316 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $60 | $59 | $23 | $340 |
| End Cash | $73 | $60 | $59 | $23 |
| Free Cash Flow | -$83 | -$128 | -$139 | -$170 |